Randomized Controlled Trial of Once-Daily Tenofovir, Lamivudine, and Lopinavir/Ritonavir Versus Remaining on the Same Regimen in Virologically Suppressed HIV-Infected Patients on Their First PI-Containing HAART Regimen

Controlled Trial ◽

Once Daily ◽

DURATION-8 Randomized Controlled Trial 104-Week Results—Once-Weekly Exenatide (ExQW) plus Once-Daily Dapagliflozin (DAPA) vs. ExQW or DAPA Alone

Diabetes ◽

10.2337/db18-104-lb ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 104-LB ◽

Cited By ~ 3

Author(s):

SERGE JABBOUR ◽

CRISTIAN GUJA ◽

ELISE HARDY ◽

SUDIPTA BHATTACHARYA ◽

PETER K. OHMAN ◽

...

Keyword(s):

Controlled Trial ◽

Once Daily ◽

Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2021.01.027 ◽

2021 ◽

Author(s):

Azmi Nasser ◽

Tesfaye Liranso ◽

Toyin Adewole ◽

Nicholas Fry ◽

Joseph T. Hull ◽

...

Keyword(s):

Controlled Trial ◽

Phase Iii ◽

Once Daily ◽

School Aged Children ◽

Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2010.01351.x ◽

2011 ◽

Vol 13 (3) ◽

pp. 268-275 ◽

Cited By ~ 41

Author(s):

P. Hollander ◽

K. Raslova ◽

T. V. Skjøth ◽

J. Råstam ◽

J. F. Liutkus

Keyword(s):

Insulin Detemir ◽

Controlled Trial ◽

Efficacy And Safety ◽

Once Daily ◽

A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study)

AIDS Research and Therapy ◽

10.1186/1742-6405-6-3 ◽

2009 ◽

Vol 6 (1) ◽

pp. 3 ◽

Cited By ~ 15

Author(s):

Princy N Kumar ◽

Patricia Salvato ◽

Anthony LaMarca ◽

Edwin DeJesus ◽

Parul Patel ◽

...

Keyword(s):

Controlled Trial ◽

Once Daily ◽

Reply to Letter to the Editor: Effect of Tadalafil Once Daily (OaD) on Penile Length Loss and Morning Erections in Patients Post Bilateral Nerve-sparing Radical Prostatectomy (nsRP): Results From a Randomized Controlled Trial (Urology 2015;85:1090-1096)

Urology ◽

10.1016/j.urology.2015.09.013 ◽

2015 ◽

Vol 86 (6) ◽

pp. 1243-1244

Author(s):

Gerald Brock ◽

John Mulhall ◽

Carsten Henneges ◽

Hartwig Büttner

Keyword(s):

Radical Prostatectomy ◽

Controlled Trial ◽

Nerve Sparing ◽

Penile Length ◽

Once Daily ◽

Randomized Controlled ◽

Letter To The Editor ◽

Editor Effect

Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: A randomized controlled trial

Scandinavian Journal of Infectious Diseases ◽

10.1080/00365540701383147 ◽

2007 ◽

Vol 39 (10) ◽

pp. 896-901 ◽

Cited By ~ 9

Author(s):

Malee Techapornroong ◽

Chusana Suankratay

Keyword(s):

Amphotericin B ◽

Cryptococcal Meningitis ◽

Controlled Trial ◽

Daily Administration ◽

Once Daily ◽

Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2005.12.1358 ◽

2006 ◽

Vol 117 (4) ◽

pp. 802-809 ◽

Cited By ~ 355

Author(s):

S DURHAM ◽

W YANG ◽

M PEDERSEN ◽

N JOHANSEN ◽

S RAK

Keyword(s):

Sublingual Immunotherapy ◽

Controlled Trial ◽

Allergic Rhinoconjunctivitis ◽

Once Daily ◽

Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes

Diabetic Medicine ◽

10.1111/dme.12828 ◽

2015 ◽

Vol 33 (2) ◽

pp. 224-230 ◽

Cited By ~ 36

Author(s):

M. A. Bethel ◽

P. Harrison ◽

H. Sourij ◽

Y. Sun ◽

L. Tucker ◽

...

Keyword(s):

Type 2 Diabetes ◽

Platelet Reactivity ◽

Controlled Trial ◽

Once Daily ◽

Randomized Controlled ◽

Daily Aspirin

A randomized controlled trial comparing the efficacy of controlled-release oxybutynin tablets (10 mg once daily) with conventional oxybutynin tablets (5 mg twice daily) in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin

BJU International ◽

10.1046/j.1464-410x.2000.00623.x ◽

2001 ◽

Vol 85 (7) ◽

pp. 793-798 ◽

Cited By ~ 46

Author(s):

J. Birns ◽

E. Lukkari ◽

J.G. Malone-lee ◽

Keyword(s):

Controlled Release ◽

Controlled Trial ◽

Once Daily ◽

A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: Effective switch from intensive insulin therapy to the once-daily injection in patients with well-controlled type 2 diabetes

The Journal of Clinical Pharmacology ◽

10.1002/jcph.483 ◽

2015 ◽

Vol 55 (7) ◽

pp. 831-838 ◽

Cited By ~ 2

Author(s):

Yuichiro Inoue ◽

Akinobu Nakamura ◽

Yoshinobu Kondo ◽

Kumiko Hamano ◽

Shinobu Satoh ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Intensive Insulin Therapy ◽

Insulin Detemir ◽

Controlled Trial ◽

Daily Injection ◽

Once Daily ◽